0001209191-22-006836.txt : 20220203
0001209191-22-006836.hdr.sgml : 20220203
20220203164939
ACCESSION NUMBER: 0001209191-22-006836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Monahan Joseph
CENTRAL INDEX KEY: 0001861790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 22589344
MAIL ADDRESS:
STREET 1: C/O ACLARIS THERAPEUTICS, INC.
STREET 2: 640 LEE ROAD, SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-01
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001861790
Monahan Joseph
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE
PA
19087
0
1
0
0
Chief Scientific Officer
Common Stock
2022-02-01
4
M
0
1050
A
87684
D
Common Stock
193
I
By Spouse
Restricted Stock Units
2022-02-01
4
M
0
1050
0.00
D
Common Stock
1050
0
D
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
The shares underlying these restricted stock units vested on February 1, 2022.
/s/ Mark Ballantyne, Attorney-in-Fact
2022-02-03